Press release
Porcine Epidemic Diarrhea Vaccines Market Poised for 7.64 % Growth, Set to Hit $1.96 Billion by 2029
Porcine Epidemic Diarrhea Vaccines
The increasing prevalence of pig farming is expected to fuel the porcine epidemic diarrhea (PED) vaccine market. Pig farming, driven by growing demand for pork products and improvements in farming practices and technology, requires PED vaccines to prevent and manage disease outbreaks. According to the U.S. Department of Agriculture, pork production in the U.S. reached 40.6 billion pounds in 2022, marking a 1% increase from the prior year. This growth in pig farming is consequently driving the PED vaccine market.
Get Your Porcine Epidemic Diarrhea Vaccines Market Report Here:
https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report
What is the future CAGR of the porcine epidemic diarrhea vaccines market, and how will it impact industry expansion?
The porcine epidemic diarrhea vaccines market has grown strongly in recent years. It will rise from $1.67 billion in 2024 to $1.8 billion in 2025, at a CAGR of 8.0%. This growth is attributed to large-scale vaccination campaigns, expanded immunization programs, the adoption of disposable syringes, efforts to eradicate diarrhea, and initiatives like the Global Alliance for Vaccines and Immunization (GAVI).
The porcine epidemic diarrhea vaccines market is expected to grow to $2.42 billion by 2029, with a CAGR of 7.6%. Growth is attributed to expanded immunization programs, increased vaccine development pipelines, rising pig populations, improved cold chain management, and growing awareness of preventive healthcare. Major trends include innovations in vaccine delivery devices, needle-free solutions, personalized medicine, self-administered vaccines, and stronger animal healthcare infrastructure.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp
What are the most significant trends transforming the porcine epidemic diarrhea vaccines market today?
Companies in the porcine epidemic diarrhea vaccines market are focusing on developing new products, like the porcine parvovirus (PPV) vaccine, to strengthen their market position. The PPV vaccine is designed to prevent reproductive failure in pigs caused by the PPV virus, which leads to infertility, stillbirths, and weak piglets. In March 2022, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched the ReproCyc ParvoFLEX PPV vaccine, which offers comprehensive protection against PPV-induced reproductive issues, helping maintain the health and productivity of pig herds.
Which key market segments comprise the porcine epidemic diarrhea vaccines market and drive its revenue growth?
The porcine epidemic diarrhea vaccines market covered in this report is segmented -
1) By Product: Live Vaccines, Killed Vaccines
2) By Application: Piglets, Adults Pigs
3) By End-User: Veterinary Hospitals, Hog Production Farms
Subsegments:
1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines
2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16514
What regions are at the forefront of porcine epidemic diarrhea vaccines market expansion?
Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the leading players fueling growth in the porcine epidemic diarrhea vaccines market?
Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Santé Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., ID*T Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=16514&type=smp
What Is Covered In The Porcine Epidemic Diarrhea Vaccines Global Market Report?
•Market Size Forecast: Examine the porcine epidemic diarrhea vaccines market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the porcine epidemic diarrhea vaccines market for a structured understanding.
•Key Players Overview: Analyze major players in the porcine epidemic diarrhea vaccines market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the porcine epidemic diarrhea vaccines market.
•Segment Contributions: Evaluate how different segments drive overall growth in the porcine epidemic diarrhea vaccines market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the porcine epidemic diarrhea vaccines market.
•Industry Challenges: Identify potential risks and obstacles affecting the porcine epidemic diarrhea vaccines market.
•Competitive Landscape: Review strategic developments in the porcine epidemic diarrhea vaccines market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Porcine Epidemic Diarrhea Vaccines Market Poised for 7.64 % Growth, Set to Hit $1.96 Billion by 2029 here
News-ID: 3931921 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Vaccines
Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC.
Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to…
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy…
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in…
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
